
Journal of Medicinal Chemistry p. 3684 - 3692 (1994)
Update date:2022-08-04
Topics: Synthesis Macrocyclic Design Conformational Analysis HIV-Protease Inhibitor
Podlogar
Farr
Friedrich
Tarnus
Huber
Cregge
Schirlin
Design modifications to the lead HIV-PR inhibitor 1 (MDL 73,669, K(i) = 5 nM) have been postulated based on a computational model of the 1/HIV-PR complex. A novel macrocyclic inhibitor 8 (MDL 104,168) wherein the P1 and P3 side chain
View MoreHENAN NEW BLUE CHEMICAL CO.,LTD
website:http://www.newbluechem.com
Contact:86-371-55170693/55170694
Address:Zhengzhou International Trade New Territory,Jinshui District,Zhengzhou ,China
Shanghai Balmxy Pharmaceutical Co., Ltd
Contact:0086-21-24206007
Address:Room 402, 15#, No. 909 wangyue Road, shanghai, P. R. China
Lanzhou huibang biological chemical technology Co., LTD
Contact:0931-7843964
Address:NO.2011,Yannan Road,Chengguan,
TIANJIN GST CHEMICAL TECHNOLOGY CO., LTD
Contact:+86-22-25210964
Address:Room. 208, No. -12-C, No. 13, Xinbei Road, Tanggu District, New Haixin Area, Tianjin City, China
Tianjin Ji Ping Jia Chemical Co., Ltd.
Contact:18622448868
Address:tianjin
Doi:10.1016/S0003-2670(00)87305-5
(1949)Doi:10.1007/s11243-013-9779-4
(2014)Doi:10.1016/0020-1693(94)03993-3
(1994)Doi:10.1021/jo016190t
(2002)Doi:10.1248/cpb.42.1376
(1994)Doi:10.1016/S0040-4039(00)77248-0
(1994)